BioCentury
ARTICLE | Company News

Inex management update

January 29, 2001 8:00 AM UTC

Inex Pharmaceuticals Corp. (TSE:IEX), Burnaby, B.C. Business: Cancer, Gene/Cell therapy Transition: Ian MacLachlan as CSO of IEX’s Protiva Biotherapeutics Inc. subsidiary from head of IEX’s gene del...